Antihistamines and driving ability: Evidence from 30 years Dutch on-road driving research

Background: Since all antihistamines are capable of crossing the blood-brain barrier, they may also cause sedation which may impair daily activities such as driving a car. The purpose of this review was to examine the effects of antihistamines on driving ability. Method: A literature search revealed 18 double-blind placebo-controlled clinical trials that applied the on-road highway driving test. In this test, subjects are instructed to drive 100-km on a public highway with a steady lateral position and a constant speed (95 km/h). Primary outcome measure is the Standard Deviation of Lateral Pos... Mehr ...

Verfasser: Verster, J.C.
Van De Loo, A.J.A.E.
Garssen, J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2015
Schlagwörter: antihistaminic agent / fexofenadine / levocetirizine / triprolidine / placebo / ebastine / diphenhydramine / bilastine / emedastine / clemastine / mizolastine / hydroxyzine / dexchlorpheniramine / mequitazine / cetirizine / terfenadine / loratadine / desloratadine / acrivastine / rupatadine / driving ability / European / allergy / clinical immunology / human / sedation / highway / car / blood brain barrier / single drug dose / controlled clinical trial (topic) / clinical trial (topic) / velocity / recommended drug dose / acute drug administration
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29038380
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/330091